Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.
PloS one 2013 8 (7): e68920.
Corsetti James P, Salzman Peter, Ryan Dan, Moss Arthur J, Zareba Wojciech, Sparks Charles
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 20, 2019
- Content source: